Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resistance rates among antiretroviral regimens in pregnant people living with HIV.
da Silveira Gouvêa MIF, de Lourdes Benamor Teixeira M, Fuller T, Sodré MCMP, Medeiros AF, de Mattos Salgueiro M, da Silveira Bressan C, Braga CM, da Silva PA, Mendes-Silva W, Moreira C, Jundi F, Cruz ML, Ceci L, Lattanzi FP, João EC. da Silveira Gouvêa MIF, et al. Among authors: jundi f. HIV Med. 2023 Sep;24(9):1020-1025. doi: 10.1111/hiv.13498. Epub 2023 May 4. HIV Med. 2023. PMID: 37143179
Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.
Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, Cruz ML, Pinto J, Allison S, Hazra R; NISDI PLACES Study Group. Duarte HA, et al. Braz J Infect Dis. 2015 May-Jun;19(3):263-71. doi: 10.1016/j.bjid.2015.01.004. Epub 2015 Mar 3. Braz J Infect Dis. 2015. PMID: 25743569 Free PMC article.
Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries.
Machado ES, Krauss MR, Megazzini K, Coutinho CM, Kreitchmann R, Melo VH, Pilotto JH, Ceriotto M, Hofer CB, Siberry GK, Watts DH; NICHD International Site Development Initiative (NISDI) Pediatric Protocol. Machado ES, et al. J Infect. 2014 Jun;68(6):572-80. doi: 10.1016/j.jinf.2013.12.018. Epub 2014 Jan 23. J Infect. 2014. PMID: 24462561 Free PMC article.
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Ruel TD, Acosta EP, Liu JP, Gray KP, George K, Montañez N, Popson S, Buchanan AM, Bartlett M, Dayton D, Anthony P, Brothers C, Vavro C, Singh R, Koech L, Vhembo T, Mmbaga BT, Pinto JA, Dobbels EFM, Archary M, Chokephaibulkit K, Ounchanum P, Deville JG, Hazra R, Townley E, Wiznia A; IMPAACT P1093 team. Ruel TD, et al. Lancet HIV. 2022 May;9(5):e332-e340. doi: 10.1016/S2352-3018(22)00044-3. Lancet HIV. 2022. PMID: 35489377 Free PMC article. Clinical Trial.